Corbus Pharmaceuticals Holdings (CRBP) Amortizatization of Intangibles (2018 - 2025)

Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Amortizatization of Intangibles of $674000.0 in Q3 2025, up 430.39% quarter-over-quarter from -$204000.0 in Q2 2025, and down 69.08% on a YoY basis from $2.2 million in Q3 2024.

Corbus Pharmaceuticals Holdings (CRBP) Amortizatization of Intangibles (2018 - 2025) Analysis & Trends

Corbus Pharmaceuticals Holdings' Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $674000.0 for Q3 2025.

  • In Q3 2025, Amortizatization of Intangibles fell 69.08% year-over-year to $674000.0; the TTM figure through Sep 2025 stood at $1.5 million (down 41.82% YoY), while the FY2024 annual figure was $3.3 million, up 557.51% from the prior year.
  • Amortizatization of Intangibles was $674000.0 for Q3 2025 at Corbus Pharmaceuticals Holdings, up from -$204000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $2.2 million in Q3 2024 to a low of -$838299.0 in Q2 2022.
  • Historically, Amortizatization of Intangibles has averaged $267512.5 across 5 years, with a median of $173810.0 in 2021.
  • Biggest YoY gain for Amortizatization of Intangibles was 6870.72% in 2022; the steepest drop was 582.31% in 2022.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $339286.0 in 2021, then tumbled by 295.92% to -$664742.0 in 2022, then soared by 112.03% to $80000.0 in 2023, then jumped by 933.75% to $827000.0 in 2024, then retreated by 18.5% to $674000.0 in 2025.
  • The last three Amortizatization of Intangibles figures came in at $674000.0 (Q3 2025), -$204000.0 (Q2 2025), and $204000.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 13,267.00
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Corbus Pharmaceuticals Holdings 135.08 Mn 107.27 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 674,000.00
Sep 30, 2025 674,000.00
Jun 30, 2025 -204,000.00
Jun 30, 2025 -204,000.00
Mar 31, 2025 204,000.00
Mar 31, 2025 204,000.00
Dec 31, 2024 827,000.00
Dec 31, 2024 827,000.00
Sep 30, 2024 2.18 Mn
Sep 30, 2024 2.18 Mn
Jun 30, 2024 132,000.00
Jun 30, 2024 132,000.00
Mar 31, 2024 188,000.00
Mar 31, 2024 188,000.00
Dec 31, 2023 80,000.00
Dec 31, 2023 80,000.00
Sep 30, 2023 147,000.00
Sep 30, 2023 147,000.00
Jun 30, 2023 77,092.00
Jun 30, 2023 77,092.00